166 related articles for article (PubMed ID: 1091152)
1. Metabolic bone disease in chronic renal failure. II. Renal transplant patients.
Huffer WE; Kuzela D; Popovtzer MM; Starzl TE
Am J Pathol; 1975 Mar; 78(3):385-400. PubMed ID: 1091152
[TBL] [Abstract][Full Text] [Related]
2. Metabolic bone disease in chronic renal failure. I. Dialyzed uremics.
Huffer WE; Kuzela D; Popovtzer MM
Am J Pathol; 1975 Mar; 78(3):365-84. PubMed ID: 1119535
[TBL] [Abstract][Full Text] [Related]
3. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G
Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
6. Bone disease in long-term renal transplant recipients with severe osteopenia: a cross-sectional study.
Rolla D; Ballanti P; Marsano L; Bianchi G; Messa P; Paoletti E; Cannella G
Transplantation; 2006 Mar; 81(6):915-21. PubMed ID: 16570017
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral content in chronic renal failure and after renal transplantation.
Dalén N; Alvestrand A
Clin Nephrol; 1973; 1(6):338-46. PubMed ID: 4594997
[No Abstract] [Full Text] [Related]
8. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
9. Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis.
Faugere MC; Arnala IO; Ritz E; Malluche HH
J Lab Clin Med; 1986 Jun; 107(6):481-7. PubMed ID: 3486929
[TBL] [Abstract][Full Text] [Related]
10. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in kidney transplant recipients and patients on hemodialysis: a comparison with healthy individuals.
Nouri-Majalan N; Sanadgol H; Rahimian M; Soleimani H
Iran J Kidney Dis; 2008 Jul; 2(3):154-9. PubMed ID: 19377230
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
Marcén R; Caballero C; Uriol O; Fernández A; Villafruela JJ; Pascual J; Martins J; Rodriguez N; Burgos FJ; Ortuño J
Transplant Proc; 2007 Sep; 39(7):2256-8. PubMed ID: 17889156
[TBL] [Abstract][Full Text] [Related]
13. Hyperparathyroid bone disease in diabetic renal failure.
Cundy TF; Humphreys S; Watkins PJ; Parsons V
Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
[TBL] [Abstract][Full Text] [Related]
14. Bone loss in pediatric renal transplant recipients.
el-Husseini AA; el-Agroudy AE; Sobh MA; Ghoneim MA
Nefrologia; 2003; 23 Suppl 2():131-4. PubMed ID: 12778870
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
Kuo PC; Luikart H; Busse-Henry S; Hunt SA; Valantine HA; Stinson EB; Oyer PE; Scandling JD; Alfrey EJ; Dafoe DC
Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
[TBL] [Abstract][Full Text] [Related]
16. Impact of cadaveric renal transplantation on survival in patients listed for transplantation.
Oniscu GC; Brown H; Forsythe JL
J Am Soc Nephrol; 2005 Jun; 16(6):1859-65. PubMed ID: 15857921
[TBL] [Abstract][Full Text] [Related]
17. Determinants of bone mass in end-stage renal failure patients at the time of kidney transplantation.
Dolgos S; Hartmann A; Bønsnes S; Ueland T; Isaksen GA; Godang K; Pfeffer P; Bollerslev J
Clin Transplant; 2008; 22(4):462-8. PubMed ID: 18318737
[TBL] [Abstract][Full Text] [Related]
18. [Renal graft survival in patients with systemic lupus erythematosus].
Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
[TBL] [Abstract][Full Text] [Related]
19. Bone disease after renal transplantation.
Weisinger JR; Carlini RG; Rojas E; Bellorin-Font E
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1300-13. PubMed ID: 17699362
[TBL] [Abstract][Full Text] [Related]
20. The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.
Sahin G; Yasar NS; Sirmagul B; Bal C; Yalcin AU
Ren Fail; 2008; 30(10):992-9. PubMed ID: 19016151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
